Clinical Trial Details
| Trial ID: | L4617 |
| Source ID: | NCT01452113 |
| Associated Drug: | Vildagliptin |
| Title: | Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy |
| Acronym: | DPPNAC |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: Vildagliptin |
| Outcome Measures: | Primary: plasma glucagon concentration, 120 min post stantardized meal | Secondary: GLP-1, T-30, 0, 15, 30, 60, 90, 120, 180 min post standardized meal|GIP, T-30,0, 15, 30, 60, 90, 120, 180 min post standardized meal |
| Sponsor/Collaborators: | Sponsor: University Hospital, Toulouse | Collaborators: Institute of Molecular Medicine of Rangueil (I2MR)|Faculty of Medicine, Toulouse|Novartis Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 21 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE |
| Start Date: | 2010-10 |
| Completion Date: | 2013-03 |
| Results First Posted: | |
| Last Update Posted: | 2014-03-12 |
| Locations: | UH Toulouse, Toulouse, 31059, France |
| URL: | https://clinicaltrials.gov/show/NCT01452113 |
